ACRX AcelRx Pharmaceuticals Inc Analyst Estimates & Rating

The largest positive contribution comes from its “Physical diseases” impact, which is false driven by its “Sufentanil” and “Clinical research services for physiological diseases ” products. AcelRx Pharmaceuticals does not have a long track record of dividend growth. Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment. For US and Canadian Stocks, the Overview page includes key statistics on the stock’s fundamentals, with a link to see more. Barchart is committed to ensuring digital accessibility for individuals with disabilities.

The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Hayward, CA. AcelRx Pharmaceuticals has a short interest ratio (“days to cover”) of 3.6, which is generally considered an acceptable ratio of short interest to trading volume. The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities. The technique has proven to be very useful for finding positive surprises. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.

A valuation method that multiplies the price of a company’s stock by the total number of outstanding shares. The price-earnings ratio is a company’s share price to the company’s Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued. The price-to-book ratio is a company’s current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.

Value Stocks In The Healthcare Sector

To see all exchange delays and terms of use please see Barchart’s disclaimer. AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm’s portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03.

• It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
• AcelRx Pharmaceuticals Inc share price live 0.6614, this page displays NASDAQ ACRX stock exchange data.
• Highlights important summary options statistics to provide a forward looking indication of investors’ sentiment.

AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Hayward, California. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year.

Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an “uptick” in price and the value of trades made on a “downtick” in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades.

Acelrx Pharmaceuticals Inc 52 week low is $0.5687 as of May 01, 2023. 52 week high is the highest price of a stock in the past 52 weeks, or one year. Acelrx Pharmaceuticals Inc 52 week high is $7.60 as of May 01, 2023.

NEW YORK — https://1investing.in/ of AcelRx Pharmaceuticals plummeted 39% in active, premarket trade Monday, after the drug company said the U.S. Food and Drug Administration surprisingly requested and additional study to … This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies. AcelRx Pharmaceuticals delivered earnings and revenue surprises of 21.67% and 7.82%, respectively, for the quarter ended September 2022. AcelRx Pharmaceuticals delivered earnings and revenue surprises of -900% and 97.04%, respectively, for the quarter ended December 2022.

Fed Meet, ECB Meet Among Key Events in Busy Holiday-Truncated Week

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

If you have issues, please download one of the browsers listed here. Measures how much net income or profit is generated as a percentage of revenue.

It’s calculated by averaging the closing stock price over the previous 50 trading days. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals.

Small-Cap Bank Hits New 52-Week High on Strong Q4 Profit, Operating Performance

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive. Real-time analyst ratings, insider transactions, earnings data, and more. Live educational sessions using site features to explore today’s markets. Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Telecoms, Consumer Services and Oil & Gas sectors propelled shares lower.

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. Intraday Data provided by FACTSET and subject to terms of use. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Enterprise Value is a measure of a company’s total value, often used as a more comprehensive alternative to equity market capitalization.

Net money flow is the value of uptick trades minus the value of downtick trades. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Research Report for ACRX

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed.

Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. After each calculation the program assigns a Buy, Sell, or Hold value with the study, depending on where the price lies in reference to the common interpretation of the study. For example, a price above its moving average is generally considered an upward trend or a buy.

These returns cover a period from January 1, 1988 through April 3, 2023. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return.

It stands for top three most successful forex traders ever before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Advanced Niyad™ supply chain development with a focus on obtaining an Emergency Use Authorization in 2023 $0.6 million net revenue in Q2 2022; fifth consecutive quarter of commercial (ex-DoD) sales vo… Patients reported lower pain scores, required fewer rescue doses and had a shorter hospital stay than patients receiving continuous femoral nerve block This study of patients following knee replacemen… A new, potent opioid medication intended for immediate pain relief has become the center of a maelstrom of controversy as it nears a Food and Drug Administration approval decision early next month. AcelRx Pharmaceuticals’ stock is owned by many different institutional and retail investors.

We are continuously working to improve our web experience, and encourage users to Contact Us for feedback and accommodation requests. Long term indicators fully support a continuation of the trend. These three penny stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching. Divestment of DSUVIA® to Alora Pharmaceuticals expected to close the week of April 3, 2023 AcelRx advancing its proprietary Niyad™ nafamastat program with FDA… Your browser of choice has not been tested for use with Barchart.com.

Top institutional investors include Simplex Trading LLC (0.00%). Insiders that own company stock include Adrian Adams and Vincent J Angotti. The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. Get MarketBeat All Access Free for 30 DaysJoin thousands of other investors who make better investing decisions with our premium tools.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value.

Brigham and Women’s Hospital study found that SST-treated patients had significantly lower pain scores in the post-operative care unit compared with patients in the two intravenous opioid contr… Study is the first to report on the use of DSUVIA® in the rapidly growing field of rhinology where otolaryngologists are performing painful nasal and sinus procedures in the office which were historic… Divestment of DSUVIA® to Alora Pharmaceuticals expected to close the week of April 3, 2023 AcelRx advancing its proprietary Niyad™ nafamastat program with FDA Breakthrough designation in line with a s… In connection with closing, AcelRx received approximately $2.7 million from Alora Pharmaceuticals and Aguettant AcelRx announces full repayment of its senior loan with Oxford Finance HAYWARD, Calif. ,…